BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16891872)

  • 1. Angiogenesis in colorectal cancer: prognostic and therapeutic implications.
    Giatromanolaki A; Sivridis E; Koukourakis MI
    Am J Clin Oncol; 2006 Aug; 29(4):408-17. PubMed ID: 16891872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of angiogenesis in colorectal cancer.
    Papamichael D
    Anticancer Res; 2001; 21(6B):4349-53. PubMed ID: 11908690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and endometrial cancer.
    Sivridis E
    Anticancer Res; 2001; 21(6B):4383-8. PubMed ID: 11908694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The present and future of angiogenesis-directed treatments of colorectal cancer.
    O'Dwyer PJ
    Oncologist; 2006 Oct; 11(9):992-8. PubMed ID: 17030640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and its role in colorectal tumor and metastasis formation.
    Ellis LM
    Semin Oncol; 2004 Dec; 31(6 Suppl 17):3-9. PubMed ID: 15696024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-associated angiogenesis in human colorectal cancer.
    Rmali KA; Puntis MC; Jiang WG
    Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver metastasis in colorectal cancer and tumor angiogenesis].
    Xie Z; Huang X; Li J; Zhou L
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):336-7, 21. PubMed ID: 11829853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
    Nakamoto RH; Uetake H; Iida S; Kolev YV; Soumaoro LT; Takagi Y; Yasuno M; Sugihara K
    Jpn J Clin Oncol; 2007 Sep; 37(9):679-85. PubMed ID: 17846040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic therapy against gastrointestinal tract cancers.
    Iwasaki J; Nihira S
    Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of anti-vascular endothelial growth factor therapies with cytotoxic chemotherapy in the treatment of colorectal cancer.
    Oliveira SC; Machado KK; Sabbaga J; Hoff PM
    Cancer J; 2010; 16(3):220-5. PubMed ID: 20526100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
    Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
    Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
    Ellis LM
    Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma.
    Liu J; Duan Y; Cheng X; Chen X; Xie W; Long H; Lin Z; Zhu B
    Biochem Biophys Res Commun; 2011 Apr; 407(2):348-54. PubMed ID: 21396350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and hypoxic factors in colorectal cancer.
    Rasheed S; McDonald PJ; Northover JM; Guenther T
    Pathol Res Pract; 2008; 204(7):501-10. PubMed ID: 18541387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiogenesis and hematologic malignancy].
    Zini JM; Tobelem G
    Bull Cancer; 2007 Jul; 94 Spec No():S241-6. PubMed ID: 17846010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in colorectal cancer: therapeutic implications and future directions.
    Allen J; Bergsland EK
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1087-119, ix. PubMed ID: 15474337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of angiogenesis and clinical application of anti-angiogenesis].
    Takahashi Y; Mai M
    Nihon Geka Gakkai Zasshi; 2001 May; 102(5):381-4. PubMed ID: 11394000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.